BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28209486)

  • 1. Vasodilator-Stimulated Phosphoprotein (VASP) depletion from breast cancer MDA-MB-231 cells inhibits tumor spheroid invasion through downregulation of Migfilin, β-catenin and urokinase-plasminogen activator (uPA).
    Gkretsi V; Stylianou A; Stylianopoulos T
    Exp Cell Res; 2017 Mar; 352(2):281-292. PubMed ID: 28209486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migfilin interacts with vasodilator-stimulated phosphoprotein (VASP) and regulates VASP localization to cell-matrix adhesions and migration.
    Zhang Y; Tu Y; Gkretsi V; Wu C
    J Biol Chem; 2006 May; 281(18):12397-407. PubMed ID: 16531412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Ras suppressor-1 (RSU-1) as a potential breast cancer metastasis biomarker using a three-dimensional in vitro approach.
    Gkretsi V; Stylianou A; Louca M; Stylianopoulos T
    Oncotarget; 2017 Apr; 8(16):27364-27379. PubMed ID: 28423706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
    Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
    Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of SNHG15 facilitates cell proliferation, migration, invasion and suppresses cell apoptosis in breast cancer by regulating miR-411-5p/VASP axis.
    Liu LB; Jiang ZJ; Jiang XL; Wang S
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1899-1912. PubMed ID: 32141559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple actin binding domains of Ena/VASP proteins determine actin network stiffening.
    Gentry BS; van der Meulen S; Noguera P; Alonso-Latorre B; Plastino J; Koenderink GH
    Eur Biophys J; 2012 Nov; 41(11):979-90. PubMed ID: 23052975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of Ras Suppressor-1 (RSU-1) promotes cell invasion of breast cancer cells through a compensatory upregulation of a truncated isoform.
    Gkretsi V; Kalli M; Efstathiades C; Papageorgis P; Papanikolaou V; Zacharia LC; Tsezou A; Athanassiou E; Stylianopoulos T
    Sci Rep; 2019 Jul; 9(1):10050. PubMed ID: 31296919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
    Moreau M; Mourah S; Dosquet C
    Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
    Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
    Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ultrastructure of MCF-7 Breast Cancer Cells after Vasodilator-Stimulated Phosphoprotein Knockdown.
    Wang Y; Su K; Hu PC; Gao FF; Zhang JW; Wei L
    Ultrastruct Pathol; 2015; 39(5):318-23. PubMed ID: 26107555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-610 inhibits the migration and invasion of gastric cancer cells by suppressing the expression of vasodilator-stimulated phosphoprotein.
    Wang J; Zhang J; Wu J; Luo D; Su K; Shi W; Liu J; Tian Y; Wei L
    Eur J Cancer; 2012 Aug; 48(12):1904-13. PubMed ID: 22189055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental evidence of Migfilin as a new therapeutic target of hepatocellular carcinoma metastasis.
    Gkretsi V; Bogdanos DP
    Exp Cell Res; 2015 Jun; 334(2):219-27. PubMed ID: 25773778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icariin exterts negative effects on human gastric cancer cell invasion and migration by vasodilator-stimulated phosphoprotein via Rac1 pathway.
    Wang Y; Dong H; Zhu M; Ou Y; Zhang J; Luo H; Luo R; Wu J; Mao M; Liu X; Zhang J; Wei L
    Eur J Pharmacol; 2010 Jun; 635(1-3):40-8. PubMed ID: 20307526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1α acts downstream of TNF-α to inhibit vasodilator-stimulated phosphoprotein expression and modulates the adhesion and proliferation of breast cancer cells.
    Su K; Tian Y; Wang J; Shi W; Luo D; Liu J; Tong Z; Wu J; Zhang J; Wei L
    DNA Cell Biol; 2012 Jun; 31(6):1078-87. PubMed ID: 22320863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
    Holst-Hansen C; Johannessen B; Høyer-Hansen G; Rømer J; Ellis V; Brünner N
    Clin Exp Metastasis; 1996 May; 14(3):297-307. PubMed ID: 8674284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilator-stimulated phosphoprotein restricts cell-to-cell spread of Shigella flexneri at the cell periphery.
    Lee SY; Gertler FB; Goldberg MB
    Microbiology (Reading); 2015 Nov; 161(11):2149-60. PubMed ID: 26358985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.
    Montgomery N; Hill A; McFarlane S; Neisen J; O'Grady A; Conlon S; Jirstrom K; Kay EW; Waugh DJ
    Breast Cancer Res; 2012 May; 14(3):R84. PubMed ID: 22621373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actin polymerization in differentiated vascular smooth muscle cells requires vasodilator-stimulated phosphoprotein.
    Kim HR; Graceffa P; Ferron F; Gallant C; Boczkowska M; Dominguez R; Morgan KG
    Am J Physiol Cell Physiol; 2010 Mar; 298(3):C559-71. PubMed ID: 20018948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasodilator-stimulated phosphoprotein regulates osteosarcoma cell migration.
    Wu G; Wei L; Yu A; Zhang M; Qi B; Su K; Hu X; Wang J
    Oncol Rep; 2011 Dec; 26(6):1609-15. PubMed ID: 21874265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of profilin-1 expression enhances breast cancer cell motility by Ena/VASP proteins.
    Bae YH; Ding Z; Zou L; Wells A; Gertler F; Roy P
    J Cell Physiol; 2009 May; 219(2):354-64. PubMed ID: 19115233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.